20,078
Participants
Start Date
April 30, 2003
Primary Completion Date
December 31, 2005
Study Completion Date
December 31, 2005
Fondaparinux
fondaparinux 2.5 mg, s.c. injection once daily x 8 days or Hospital Discharge if earlier and placebo-enoxaparin 1mg/kg s.c. injection twice daily x 2-8 days or until clinically stable
enoxaparin
enoxaparin 1mg/kg s.c. injection twice daily x 2 to 8 days
Lead Sponsor
Collaborators (3)
University of Chicago
OTHER
Organon
INDUSTRY
Sanofi
INDUSTRY
Duke University
OTHER
GlaxoSmithKline
INDUSTRY